AbbVie
ABBV
#30
Rank
S$420.45 B
Marketcap
$237.93
Share price
2.37%
Change (1 day)
17.55%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$186.12 Billion

According to AbbVie's latest financial reports the company's total liabilities are S$186.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$164.18 B0.78%
2022-12-31S$162.90 B-8.08%
2021-12-31S$177.22 B-2.55%
2020-12-31S$181.86 B38.66%
2019-12-31S$131.16 B41.61%
2018-12-31S$92.62 B5.42%
2017-12-31S$87.85 B-1.23%
2016-12-31S$88.95 B28.07%
2015-12-31S$69.46 B103.98%
2014-12-31S$34.05 B8.79%
2013-12-31S$31.30 B8.25%
2012-12-31S$28.91 B194.21%
2011-12-31S$9.82 B40.47%
2010-12-31S$6.99 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$171.98 B-7.60%๐Ÿ‡บ๐Ÿ‡ธ USA
S$103.62 B-44.33%๐Ÿ‡บ๐Ÿ‡ธ USA
S$83.04 B-55.38%๐Ÿ‡บ๐Ÿ‡ธ USA
S$112.95 B-39.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$48.96 B-73.69%๐Ÿ‡บ๐Ÿ‡ธ USA
S$16.19 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
S$80.87 B-56.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$86.88 B-53.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$1.10 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA